These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers. Sun DD, Lee PI. J Control Release; 2015 Aug 10; 211():85-93. PubMed ID: 26054795 [Abstract] [Full Text] [Related]
23. Deconstructing HPMCAS: Excipient Design to Tailor Polymer-Drug Interactions for Oral Drug Delivery. Ting JM, Navale TS, Jones SD, Bates FS, Reineke TM. ACS Biomater Sci Eng; 2015 Oct 12; 1(10):978-990. PubMed ID: 33429529 [Abstract] [Full Text] [Related]
27. The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement. Ueda K, Higashi K, Yamamoto K, Moribe K. Int J Pharm; 2014 Apr 10; 464(1-2):205-13. PubMed ID: 24440403 [Abstract] [Full Text] [Related]
28. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations. Xie T, Taylor LS. Pharm Res; 2016 Mar 10; 33(3):739-50. PubMed ID: 26563205 [Abstract] [Full Text] [Related]
33. Second harmonic generation microscopy as a tool for the early detection of crystallization in spray dried dispersions. Correa-Soto C, Trasi NS, Schmitt PD, Su Y, Liu Z, Miller E, Variankaval N, Marsac PJ, Simpson GJ, Taylor LS. J Pharm Biomed Anal; 2017 Nov 30; 146():86-95. PubMed ID: 28866472 [Abstract] [Full Text] [Related]
34. Aggregated Solution Morphology of Poly(acrylic acid)-Poly(styrene) Block Copolymers Improves Drug Supersaturation Maintenance and Caco-2 Cell Membrane Permeation. Purchel AA, Boyle WS, Reineke TM. Mol Pharm; 2019 Nov 04; 16(11):4423-4435. PubMed ID: 31633362 [Abstract] [Full Text] [Related]
35. The twofold advantage of the amorphous form as an oral drug delivery practice for lipophilic compounds: increased apparent solubility and drug flux through the intestinal membrane. Dahan A, Beig A, Ioffe-Dahan V, Agbaria R, Miller JM. AAPS J; 2013 Apr 04; 15(2):347-53. PubMed ID: 23242514 [Abstract] [Full Text] [Related]
37. Formulation and in vivo hypoglycemic effect of glipizide solid dispersion. Patel GC, Asodaria KV, Patel HP, Shah DR. Curr Drug Deliv; 2012 Jul 04; 9(4):395-404. PubMed ID: 22640037 [Abstract] [Full Text] [Related]
38. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine. Konno H, Handa T, Alonzo DE, Taylor LS. Eur J Pharm Biopharm; 2008 Oct 04; 70(2):493-9. PubMed ID: 18577451 [Abstract] [Full Text] [Related]